An internal review published by the U.S. Food and Drug Administration (FDA) on Tuesday found that multiple factors hindered the agency’s response this year to the nationwide shortage of baby formula.
Steven Solomon, the head of the FDA’s veterinary division who conducted the internal review, said he found five “major areas of need” and 15 specific findings, and provided recommendations to improve the agency’s infant formula regulation and oversight.
The 10-page report (pdf) of the review is “the result of information collected from more than 40 interviews with more than 60 FDA staff and leadership directly involved with the events that transpired,” Solomon said in a statement….